Please login to the form below

Not currently logged in
Email:
Password:

European Respiratory Society

This page shows the latest European Respiratory Society news and features for those working in and with pharma, biotech and healthcare.

AZ hopes dosing will differentiate its severe asthma therapy

AZ hopes dosing will differentiate its severe asthma therapy

The UK pharma group reported the results of two studies at the European Respiratory Society (ERS) in London, which showed the interleukin-5 (IL-5) inhibitor was able to reduce attacks

Latest news

  • Roche says Esbriet boosts survival in pulmonary fibrosis Roche says Esbriet boosts survival in pulmonary fibrosis

    Positive results due to be presented at European Respiratory Society . Data due to be reported at a medical conference next week shows Roche's Esbriet can improve survival in idiopathic pulmonary ... deal. The new data - due to be presented to doctors

  • Boehringer in breach over beer drinking, lederhosen presentation Boehringer in breach over beer drinking, lederhosen presentation

    standards. The breach comes after a pulmonologist working in Germany complained about a scientific symposium organised by Boehringer at the European Respiratory Society (ERS) Congress, held in Munich last year. ... Boehringer currently markets the

  • GSK sees COPD future in triple therapy GSK sees COPD future in triple therapy

    The performance of GSK's respiratory portfolio dragged down group revenues as a whole last year, and GSK is now banking on a series of new products launches - including LAMA/LABA ... One set back for the triple therapies came last year, however, when a

  • Questions raised about affordability of asthma antibodies Questions raised about affordability of asthma antibodies

    GlaxoSmithKline (GSK) and Teva presented positive phase III trials of their respective anti-IL-5 candidates mepolizumab and reslizumab at this week's European Respiratory Society (ERS) meeting in Munich, showing

  • Boehringer's Spiriva cleared for asthma in EU Boehringer's Spiriva cleared for asthma in EU

    Approval by the European Medicines Agency (EMA) was based on the results of a phase III trial programme - called UniTinA-asthma - that collectively showed that Spiriva reduced the risk of severe ... Boehringer has also presented new data at the European

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Integrating digital: developing a social conference Integrating digital: developing a social conference

    More recently the company has been forging ahead in its use of tweetchats - during the European Respiratory Society Congress in 2013 it used this forum to spark conversations on chronic obstructive ... More recently it engaged digital efforts for a

  • Case study: Innovation in symposia engagement

    Synergy Vision, a London-based medical communication agency, was tasked with leading Nycomed’s medical education and communication efforts for the third year in a row at this year’s European ... Respiratory Society (ERS) congress in Amsterdam.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics